Literature DB >> 21207143

Discovery of a β-glucosidase inhibitor from a chemically engineered extract prepared through sulfonylation.

Mario O Salazar1, Oscar Micheloni, Andrea M Escalante, Ricardo L E Furlan.   

Abstract

A semisynthetic β-glucosidase inhibitor was identified from a chemically engineered extract prepared by reaction with benzenesulfonyl chloride. The structure includes a natural histamine portion and a benzenesulfonyl portion introduced during the diversification step.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21207143     DOI： 10.1007/s11030-010-9301-2

Source DB:  PubMed          Journal:  Mol Divers        ISSN： 1381-1991            Impact factor:   2.943


  18 in total

Review 1.  Recent developments of transition-state analogue glycosidase inhibitors of non-natural product origin.

Authors:  Vinni H Lillelund; Henrik H Jensen; Xifu Liang; Mikael Bols
Journal:  Chem Rev       Date:  2002-02       Impact factor: 60.622

Review 2.  Glycosidase inhibitors as potential HIV entry inhibitors?

Authors:  Inmaculada Robina; Antonio J Moreno-Vargas; Ana T Carmona; Pierre Vogel
Journal:  Curr Drug Metab       Date:  2004-08       Impact factor: 3.731

3.  The mechanism of the sting of the common nettle (urtica urens).

Authors:  N Emmelin; W Feldberg
Journal:  J Physiol       Date:  1947-10-15       Impact factor: 5.182

4.  A rapid TLC autographic method for the detection of glucosidase inhibitors.

Authors:  Mario O Salazar; Ricardo L E Furlan
Journal:  Phytochem Anal       Date:  2007 May-Jun       Impact factor: 3.373

5.  Chemically engineered extracts: bioactivity alteration through sulfonylation.

Authors:  Mario O Salazar; I Ayelen Ramallo; Oscar Micheloni; Manuel Gonzalez Sierra; Ricardo L E Furlan
Journal:  Bioorg Med Chem Lett       Date:  2009-07-10       Impact factor: 2.823

6.  Brominated extracts as source of bioactive compounds.

Authors:  Luciana Méndez; Mario O Salazar; I Ayelen Ramallo; Ricardo L E Furlan
Journal:  ACS Comb Sci       Date:  2010-12-17       Impact factor: 3.784

7.  Histidines, histamines and imidazoles as glycosidase inhibitors.

Authors:  R A Field; A H Haines; E J Chrystal; M C Luszniak
Journal:  Biochem J       Date:  1991-03-15       Impact factor: 3.857

Review 8.  Therapeutic applications of sugar-mimicking glycosidase inhibitors.

Authors:  N Asano; A Kato; A A Watson
Journal:  Mini Rev Med Chem       Date:  2001-07       Impact factor: 3.862

9.  A rapid TLC autographic method for the detection of xanthine oxidase inhibitors and superoxide scavengers.

Authors:  I Ayelen Ramallo; Susana A Zacchino; Ricardo L E Furlan
Journal:  Phytochem Anal       Date:  2006 Jan-Feb       Impact factor: 3.373

Review 10.  Current therapies and emerging targets for the treatment of diabetes.

Authors:  A S Wagman; J M Nuss
Journal:  Curr Pharm Des       Date:  2001-04       Impact factor: 3.116
View more
  4 in total

1.  Hydrazine-Containing Heterocycle Cytochalasan Derivatives From Hydrazinolysis of Extracts of a Desert Soil-Derived Fungus Chaetomium madrasense 375.

Authors:  Qingfeng Guo; Jinhua Chen; Yuwei Ren; Zhenhua Yin; Juanjuan Zhang; Baocheng Yang; Xuewei Wang; Wenbing Yin; Wancun Zhang; Gang Ding; Lin Chen
Journal:  Front Chem       Date:  2021-04-21       Impact factor: 5.221

2.  N α-arylsulfonyl histamines as selective β-glucosidase inhibitors.

Authors:  M O Salazar; M I Osella; I A Ramallo; R L E Furlan
Journal:  RSC Adv       Date:  2018-10-24       Impact factor: 3.361

3.  Arylsulfonyl histamine derivatives as powerful and selective α-glucosidase inhibitors.

Authors:  M I Osella; M O Salazar; M D Gamarra; D M Moreno; F Lambertucci; D E Frances; R L E Furlan
Journal:  RSC Med Chem       Date:  2020-03-12

4.  A novel method for screening beta-glucosidase inhibitors.

Authors:  Sony Pandey; Ayinampudi Sree; Soumya S Dash; Dipti P Sethi
Journal:  BMC Microbiol       Date:  2013-03-08       Impact factor: 3.605
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.